MHM IVS: Financial statements 2020
CVR: 38420607
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
MHM IVS (CVR 38420607) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 748,768 and a net result of DKK 237,943 compared with DKK 55,621 the year before. That is an increase of 94% compared with the year before. Equity in the 2020 report amounted to DKK 281,613. The solvency ratio was 36.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 748,768
- Profit/Loss
- DKK 237,943
- Equity
- DKK 281,613
- Total Assets
- DKK 776,600
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 749 t. | 238 t. | 282 t. | 1 |
| 2019 | 1.6 mio. | 386 t. | 56 t. | 44 t. | - |
Official annual report
How creditworthy is MHM IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of July 1, 2020, Aous Albitar is registered as director of MHM IVS.
As of May 11, 2020, Mohammad Ismail Hamado is registered as adm. dir. of MHM IVS.
As of May 11, 2020, Moustafa Knifade has stepped down as adm. dir. of MHM IVS.
About MHM IVS
MHM IVS was a Danish company of the type Iværksætterselskab based in Hillerød, founded in 2017. The company has been dissolved on 8 February 2022. The company was registered under the industry Kombinerede serviceydelser. The company was previously named ELMADINA IVS. The company has 1 employee (2021). In 2020, the company reported a gross profit of DKK 748,768 and a net result of DKK 237,943 compared with DKK 55,621 the year before. Equity in the 2020 report amounted to DKK 281,613.